# ZNF469

## Overview
ZNF469 is a gene that encodes the zinc finger protein 469, a transcription factor belonging to the C2H2 zinc finger protein family. This protein plays a crucial role in the regulation of collagen production and the maintenance of the extracellular matrix (ECM), particularly influencing the transcription of collagen genes such as COL1A1, COL1A2, and COL3A1 (Steinhauser2024The). ZNF469 is essential for the structural integrity of connective tissues, including the cornea, where it contributes to collagen homeostasis and biomechanical strength (Lechner2014Enrichment; Moore2024An). Mutations in ZNF469 are linked to connective tissue disorders, most notably Brittle Cornea Syndrome, characterized by corneal fragility and systemic manifestations (Stanton2021A; Christensen2010Brittle). The gene's involvement in various ECM-related diseases underscores its clinical significance and the importance of its regulatory functions.

## Structure


## Function
ZNF469 is a transcription factor that plays a significant role in the regulation of collagen production and extracellular matrix (ECM) maintenance. It is a member of the C2H2 zinc finger protein family and is involved in the transcriptional regulation of collagen genes, including COL1A1, COL1A2, and COL3A1, which are crucial for collagen biosynthesis and organization (Steinhauser2024The). ZNF469 localizes to the gene bodies of collagen genes and interacts with distal regulatory elements, likely enhancers, to modulate their expression (Steinhauser2024The).

In hepatic stellate cells, ZNF469 regulates collagen production by binding to chromatin at collagen gene loci, influencing chromatin structure and transcriptional activity (Steinhauser2024The). Knockout studies have shown that the absence of ZNF469 leads to a significant reduction in collagen mRNA levels, indicating its essential role as a transcriptional regulator (Steinhauser2024The). The protein's function is conserved across species, as similar regulatory effects have been observed in mouse models (Steinhauser2024The).

ZNF469 is also implicated in maintaining the structural integrity of connective tissues, such as the cornea, where it may regulate collagen homeostasis (Lechner2014Enrichment). Its activity is crucial for the biomechanical strength of tissues, and disruptions in its function can lead to connective tissue disorders (Moore2024An).

## Clinical Significance
Mutations in the ZNF469 gene are primarily associated with Brittle Cornea Syndrome (BCS), a rare autosomal recessive disorder characterized by extreme thinning and fragility of the cornea, which can lead to rupture and potential blindness (Stanton2021A; Christensen2010Brittle). BCS is also linked to systemic manifestations such as skin hyperelasticity, joint hypermobility, and hearing loss (Rolvien2020WholeExome; Christensen2010Brittle). The condition is caused by biallelic loss-of-function mutations in ZNF469, leading to truncated, non-functional proteins that disrupt collagen synthesis and deposition in the extracellular matrix (Stanton2021A).

ZNF469 mutations have also been implicated in other connective tissue disorders, including Ehlers-Danlos syndrome and osteogenesis imperfecta, due to their role in collagen-related pathologies (Moore2024An). Variants in ZNF469 have been associated with central corneal thickness, influencing the risk of glaucoma (Lu2010Common). Additionally, ZNF469 variants have been linked to thoracic aortic aneurysm and dissection, suggesting a broader role in extracellular matrix-related diseases (Moore2024An). These findings highlight the clinical significance of ZNF469 in various connective tissue disorders and its impact on tissue integrity.

## Interactions
ZNF469 is involved in the regulation of collagen production and interacts with various proteins and nucleic acids to influence gene expression. It functions as a transcription factor, binding to promoter and enhancer elements of collagen genes such as COL1A1, COL1A2, and COL3A1, thereby regulating their transcriptional activity (Steinhauser2024The). ZNF469's interaction with chromatin is evidenced by its localization to gene bodies of collagen genes and its impact on chromatin structure, as indicated by changes in H3K27ac peaks upon ZNF469 knockout (Steinhauser2024The).

In addition to its role in collagen regulation, ZNF469 is predicted to interact with the clusterin gene (CLU), which is involved in extracellular matrix interactions and debris clearance. Variants in ZNF469 can alter CLU, potentially affecting the development of thoracic aortic aneurysm and dissection (Moore2024An). ZNF469 also interacts with the thrombospondin-1 (THBS1) gene, with variants in ZNF469 associated with decreased production of the TSP1 protein, which is linked to aortic diseases (Moore2024An).

These interactions highlight ZNF469's role in extracellular matrix regulation and its involvement in various connective tissue disorders. However, the exact mechanisms and interaction partners of ZNF469 remain to be fully elucidated.


## References


1. (Steinhauser2024The) The transcription factor ZNF469 regulates collagen production in liver fibrosis. This article has 1 citations.

[2. (Rolvien2020WholeExome) Tim Rolvien, Uwe Kornak, Stephan J. Linke, Michael Amling, and Ralf Oheim. Whole-exome sequencing identifies novel compound heterozygous znf469 mutations in two siblings with mild brittle cornea syndrome. Calcified Tissue International, 107(3):294–299, July 2020. URL: http://dx.doi.org/10.1007/s00223-020-00721-3, doi:10.1007/s00223-020-00721-3. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00223-020-00721-3)

[3. (Lechner2014Enrichment) Judith Lechner, Louise F. Porter, Aine Rice, Veronique Vitart, David J. Armstrong, Daniel F. Schorderet, Francis L. Munier, Alan F. Wright, Chris F. Inglehearn, Graeme C. Black, David A. Simpson, Forbes Manson, and Colin E. Willoughby. Enrichment of pathogenic alleles in the brittle cornea gene, znf469, in keratoconus. Human Molecular Genetics, 23(20):5527–5535, June 2014. URL: http://dx.doi.org/10.1093/hmg/ddu253, doi:10.1093/hmg/ddu253. This article has 50 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddu253)

[4. (Moore2024An) Peyton Moore, Adam Wolf, and Mohanakrishnan Sathyamoorthy. An eye into the aorta: the role of extracellular matrix regulatory genes znf469 and prdm5, from their previous association with brittle cornea syndrome to their novel association with aortic and arterial aneurysmal diseases. International Journal of Molecular Sciences, 25(11):5848, May 2024. URL: http://dx.doi.org/10.3390/ijms25115848, doi:10.3390/ijms25115848. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25115848)

5. (Stanton2021A) A Mouse Model of Brittle Cornea Syndrome caused by mutation in Zfp469. This article has 0 citations.

[6. (Christensen2010Brittle) Anne E. Christensen, Per M. Knappskog, Marit Midtbø, Clara G. Gjesdal, Jonas Mengel-From, Niels Morling, Eyvind Rødahl, and Helge Boman. Brittle cornea syndrome associated with a missense mutation in the zinc-finger 469 gene. Investigative Opthalmology &amp; Visual Science, 51(1):47, January 2010. URL: http://dx.doi.org/10.1167/iovs.09-4251, doi:10.1167/iovs.09-4251. This article has 39 citations.](https://doi.org/10.1167/iovs.09-4251)

[7. (Lu2010Common) Yi Lu, David P. Dimasi, Pirro G. Hysi, Alex W. Hewitt, Kathryn P. Burdon, Tze’Yo Toh, Jonathan B. Ruddle, Yi Ju Li, Paul Mitchell, Paul R. Healey, Grant W. Montgomery, Narelle Hansell, Timothy D. Spector, Nicholas G. Martin, Terri L. Young, Christopher J. Hammond, Stuart Macgregor, Jamie E. Craig, and David A. Mackey. Common genetic variants near the brittle cornea syndrome locus znf469 influence the blinding disease risk factor central corneal thickness. PLoS Genetics, 6(5):e1000947, May 2010. URL: http://dx.doi.org/10.1371/journal.pgen.1000947, doi:10.1371/journal.pgen.1000947. This article has 101 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1000947)